Sonoma Pharmaceuticals, Inc. Stock price
Is Sonoma Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.
Key metrics
Sonoma Pharmaceuticals, Inc. Stock Analysis
Analyst Opinions
7 Analysts have issued a Sonoma Pharmaceuticals, Inc. forecast:
Analyst Opinions
7 Analysts have issued a Sonoma Pharmaceuticals, Inc. forecast:
Sonoma Pharmaceuticals, Inc. Events
Upcoming Event
Don't miss a Thing! We will send you all news about Sonoma Pharmaceuticals, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sonoma Pharmaceuticals, Inc. Stock News
Company Profile
Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.
| Head office | United States |
| CEO | Ms. Trombly |
| Employees | 8 |
| Founded | 1999 |
| Website | sonomapharma.com |


